Author:
Amend B.,Castro-Diaz D.,Chartier-Kastler E.,De Ridder D.,Everaert K.,Spinelli M.,van Kereebroeck P.,Sievert K.-D.
Publisher
Springer Science and Business Media LLC
Reference51 articles.
1. Abrams P, Andersson KE, Birder L et al (2009) 4th International Consultation on Incontinence. Recommendations of the International Scientific Committee: Evaluation and treatment of urinary incontinence, pelvic organ prolapse and faecal incontinence. Health Publication Ltd, Plymouth UK
2. Apostolidis A, Dasgupta P, Denys P et al (2008) Recommendations on the use of botulinum toxin in the treatment of lower urinary tract disorders and pelvic floor dysfunctions: a european consensus report. Eur Urol (Epub ahead of print)
3. Apostolidis A, Dasgupta P, Fowler CJ (2006) Proposed mechanism for the efficacy of injected botulinum toxin in the treatment of human detrusor overactivity. Eur Urol 49:644–650
4. Brubaker L, Gousse A, Sand P et al (2009) Botulinum Toxin Type A (BOTOX®) Demonstrates dose-dependent efficacy and improvements in quality of life measures in patients with idiopathic OAB. IUGA
5. Chancellor MB, Chartier-Kastler EJ (2000) Principles of sacral nerve stimulation (SNS) for the treatment of bladder and urethral sphincter dysfunctions. Neuromodulation 3:16–26
Cited by
4 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献